Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies.

Acta Pharmaceutica Sinica. B
Qin WangXun Sun

Abstract

Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably promoted the development of effective therapeutic regimens of RA. Nevertheless, the inadequate response to current therapies in a proportion of patients, the systemic toxicity accompanied by long-term administration or distribution in non-targeted sites and the comprised efficacy caused by undesirable bioavailability, are still unsettled problems lying across the full remission of RA. So far, these existing limitations have inspired comprehensive academic researches on nanomedicines for RA treatment. A variety of versatile nanocarriers with controllable physicochemical properties, tailorable drug release pattern or active targeting ability were fabricated to enhance the drug delivery efficiency in RA treatment. This review aims to provide an up-to-date progress regarding to RA treatment using nanomedicines in the last 5 years and concisely discuss the potential application of several newly emerged therapeutic strategies such as inducing the antigen-specific tolerance, pro-resolving therapy or regulating the immunometabolism for RA treatments.

References

Jul 12, 2002·Arthritis Research·Gillian MurphyIan Clark
May 12, 2004·Nature Reviews. Drug Discovery·Derek W GilroyAdriano G Rossi
Nov 13, 2004·Arthritis Research & Therapy·Carol A Hitchon, Hani S El-Gabalawy
Mar 4, 2005·Arthritis Research & Therapy·Wei-Tsung ChenChing-Hsuan Tung
May 19, 2005·Arthritis Research & Therapy·Elmieke P J BootMarca H M Wauben
Sep 9, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Peter S BurrageConstance E Brinckerhoff
Jan 21, 2006·BMJ : British Medical Journal·Paul Emery
Dec 27, 2006·Biochemical and Biophysical Research Communications·Masahiko HiraiNoboru Yamazaki
Dec 24, 2008·Nature Reviews. Immunology·Mauro Perretti, Fulvio D'Acquisto
Apr 21, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hui-Fang ZhouChristine T N Pham
Aug 29, 2009·International Journal of Pharmaceutics·José L AriasAngel V Delgado
Oct 3, 2009·Nature Reviews. Rheumatology·Cornelia M WeyandJörg J Goronzy
Jul 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ying-Hua YangKamal D Moudgil
Sep 22, 2011·Current Pharmaceutical Design·Marina PierdominiciElena Ortona
Jan 11, 2012·Molecular Aspects of Medicine·Gabriella FanaliPaolo Ascenzi
Feb 24, 2012·Clinical Pharmacology and Therapeutics·Inés ColmegnaHenri A Menard
Mar 15, 2012·Current Medicinal Chemistry·M C RecioJ L Rios
Mar 22, 2012·Advanced Drug Delivery Reviews·Fang YuanDong Wang
May 31, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jonas H GraversenSøren K Moestrup
Oct 10, 2012·Nature Reviews. Rheumatology·Ulrike BaschantJan Tuckermann
Mar 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nazila KamalyOmid Cameron Farokhzad
Jul 25, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Young-Seok JungKun Na
Aug 15, 2013·Chemical Communications : Chem Comm·Seol-Hee KimJae Hyung Park
Oct 30, 2013·Drug Development and Industrial Pharmacy·Upasana BilthariyaAshish Kumar Jain
Nov 16, 2013·Therapeutic Delivery·Benjamin J BrunoCarol S Lim
Feb 12, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·A S VanniasingheV Bender
Apr 12, 2014·Expert Opinion on Biological Therapy·Homa Timlin, Clifton O Bingham
Jun 5, 2014·Chemical Communications : Chem Comm·Jung Min ShinJae Hyung Park
Jun 11, 2014·Nature Reviews. Rheumatology·Helen L WrightSteven W Edwards
Nov 12, 2014·Bioconjugate Chemistry·Hyeong Jun ByeonYu Seok Youn
Jan 21, 2015·Nature Reviews. Rheumatology·Zhan-Guo Li
Feb 18, 2015·Nature Reviews. Rheumatology·Josef S Smolen, Daniel Aletaha
Mar 4, 2015·Trends in Pharmacological Sciences·Marije I Koenders, Wim B van den Berg
Mar 4, 2015·Nature Reviews. Rheumatology·Mathieu FerrariCostantino Pitzalis
Mar 20, 2015·Drug Delivery and Translational Research·Maria-Lucia BriugliaDimitrios A Lamprou
May 10, 2015·International Journal of Pharmaceutics·Ebrahim SaadatFarid A Dorkoosh

❮ Previous
Next ❯

Citations

Sep 17, 2021·International Journal of Pharmaceutics·Rahul KumarPranava Chaudhari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.